Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.80
Ask: 3.84
Change: 0.09 (2.43%)
Spread: 0.04 (1.053%)
Open: 3.80
High: 3.80
Low: 3.80
Prev. Close: 3.71
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PHC949 product registration submitted to the EPA

31 Jan 2022 07:00

RNS Number : 0579A
Plant Health Care PLC
31 January 2022
 

RNS

 

 

31 January 2022

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

PHC949 submitted for product registration in the USA

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, announces it has submitted a new application to the US Environmental Protection Agency (EPA) for registration of its novel peptide product, PHC949, for the control of damaging soil nematodes.

 

Highlights

- PHC949 is the second new product from Plant Health Care's PREtec (Vaccines for PlantsTM) technology platform; the Company plans one major new launch every year.

- The Company is targeting PHC949 against nematodes (soil pests), a market forecast to be worth $1.6 billion globally by 2025; these pests reduce crop yields by some $100 billion annually.

- In the USA, PHC949 is being co-developed with Wilbur-Ellis for nematode control in high-value specialty crops. Wilbur-Ellis, a $3.4bn distributor of crop inputs, plans to launch the product in the second half of 2023, soon after registration by the EPA.

- Field trials of PHC949 in the USA show outstanding control of nematodes; for example, in peppers PHC949 increased marketable yield by about 3,265 lbs/acre, worth an extra $2,070/acre.

- Field trials are also underway demonstrating the value of PHC949 in soybeans and other crops in the US and Brazil.

- The Company expects global sales of PHC949 to reach into the tens of millions of dollars over the long-term and to become a significant value driver for the Company.

 

Overview

PREtec peptides (Vaccines for Plants) represent a novel class of technology which stimulates the plant to defend itself. Derived from natural proteins, PREtec is an environmentally friendly approach to protecting crops and increasing yields. PREtec peptides support conventional farming to become more sustainable. The Company has invested more than $25 million in inventing and developing the PREtec platform over the last eight years and now plans to achieve at least one major launch of a PREtec product into a major market, every year.

 

Nematode pests are found in farmland worldwide and cause extensive damage to crops, reducing yields by approximately $100 billion annually. In California alone, nematode damage results in approximately $1.6 billion in annual yield losses for almond growers.

 

PHC949 enables plants to resist nematode infestation and leads to increased plant vigor and yield in a variety of crops. Unlike traditional chemical soil fumigants used to control nematodes, PHC949 leaves beneficial soil organisms unharmed.

 

The Company has now made a regulatory submission to the Environmental Protection Agency (EPA) for the use of PHC949 to control nematodes on a wide range of crops. The EPA's evaluation process is expected to take approximately 18 months.

 

The Company is working actively with Wilbur-Ellis to ready the product for launch, soon after the EPA issues commercial regulatory permits.

 

Plans are also underway to submit PHC949 in late 2022 for registration in Brazil, setting the stage for commercialization of PHC949 for use on soybeans in Brazil in 2024.

 

Chris Richards, CEO of Plant Health Care said; "We are pleased to have achieved this critical milestone in bringing PHC949 to market and are looking forward to commercial launch in the US after regulatory approval in 2023.

 

"Given the large number of chemical nematicides that have been withdrawn from the market by regulators because of environmental concerns, farmers are clamoring for sustainable solutions to protect their crops. I am confident therefore that PHC949 will be a valuable tool for growers, offering a cost-effective and environmentally friendly way to protect their crops from destructive nematodes.

 

"The regulatory submission of PHC949 follows the introduction of Saori® in Brazil during 2021 and the planned launch of PHC279 in the USA following regulatory approval later this year. With the submission of PHC949 in the USA, we are on target to achieve at least one major launch of a PREtec product, every year. We are excited about the potential for products based on our 'Vaccines for Plants' PREtec peptides, which are targeting markets valued in total at $5 billion."

 

For further information, please contact:

 

Plant Health Care plc

Chris Richards, CEO

+1 919 926 1600

 

Arden Partners plc - Nomad & Joint Broker

John Llewellyn-Lloyd / Antonio Bossi

+44 (0) 20 7614 5900

 

Cenkos Securities plc - Joint Broker

Neil McDonald / Peter Lynch

+44 (0) 20 7391 8900

 

Vox Markets - Digital Investor Relations

Paul Cornelius / Kat Perez

+44 (0) 7866 384707

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile. Find out more at Vox Markets and the company website: www.planthealthcare.com

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEBLFXLFLEBBX
Date   Source Headline
25th Oct 20109:34 amRNSLicensing Agreement with XS Inc
1st Oct 20103:00 pmRNSTotal Voting Rights
9th Sep 20107:00 amRNSAgreement with Germains Seed Technology
1st Sep 201010:30 amRNSTotal Voting Rights
24th Aug 20103:30 pmRNSPosting of Interim Report
19th Aug 201012:30 pmRNSBlocklisting Interim Review
18th Aug 201010:15 amRNSAdditional Listing
16th Aug 20107:00 amRNSHalf Yearly Report
26th Jul 20107:00 amRNSAgreement with Syngenta Crop Protection Inc.
12th Jul 201012:30 pmRNSHolding(s) in Company
1st Jul 201010:05 amRNSHolding(s) in Company
1st Jul 201010:00 amRNSHolding(s) in Company
30th Jun 20104:45 pmRNSTotal Voting Rights
29th Jun 20109:30 amRNSHolding(s) in Company
16th Jun 201011:20 amRNSTrading Update
28th May 20107:00 amRNSSale of PHC Reclamation Inc.
10th May 20107:00 amRNSMyconate Collaboration with Brazilian Government
6th May 20107:00 amRNSMyconate Agreement with Legacy Seeds Inc
30th Apr 20109:30 amRNSTotal Voting Rights
28th Apr 20109:30 amRNSAdditional Listing
28th Apr 20107:00 amRNSPatent Application for AirStrike programme
26th Apr 20107:00 amRNSMyconate IP Agreement with Bayer CropScience
21st Apr 20106:00 pmRNSVesting of Shares under LTIP
20th Apr 20107:00 amRNSHarpin agreement with Plant Foods Inc.
15th Apr 20105:00 pmRNSResult of AGM
22nd Mar 20107:00 amRNSPatent Protection Application
15th Mar 20103:30 pmRNSDirector/PDMR Shareholding
8th Mar 201012:45 pmRNSPublication of Annual Report & Notice of AGM
1st Mar 201010:00 amRNSTotal Voting Rights
19th Feb 201010:30 amRNSDirector/PDMR Shareholding
16th Feb 201010:36 amRNSAdditional Listing and Directors' Shareholdings
16th Feb 20109:51 amRNSDual Listing on Channel Islands Stock Exchange
15th Feb 201012:26 pmRNSBlocklisting
15th Feb 20107:00 amRNSFinal Results
10th Feb 20107:00 amRNSSupply Agreement
4th Feb 20107:00 amRNSOrder for Myconate
2nd Feb 20107:00 amRNSTrial Results
1st Feb 201010:22 amRNSTotal Voting Rights
27th Jan 20107:00 amRNSTrading Statement
22nd Jan 20105:41 pmRNSAdditional Listing
12th Jan 20104:03 pmRNSDirector Declaration
31st Dec 20091:05 pmRNSTotal Voting Rights
29th Dec 20094:26 pmRNSAdditional Listing
8th Dec 20095:42 pmRNSAdditional Listing
1st Dec 200911:08 amRNSTotal Voting Rights
27th Nov 20092:55 pmRNSDirector/PDMR Shareholding
13th Nov 200911:52 amRNSHolding(s) in Company
10th Nov 20095:29 pmRNSAdditional Listing
6th Nov 200912:53 pmRNSAdditional Listing
4th Nov 20091:52 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.